Eli Lilly and Co

Johnson & Johnson

Merck & Co Inc

Roche Holding AG

AstraZeneca PLC

Novartis AG

Pfizer Inc

Sanofi SA

Bristol-Myers Squibb Co

Zoetis Inc

GSK plc

Merck KGaA

Novo Nordisk A/S

Jiangsu Hengrui Pharmaceuticals Co Ltd

Ucb SA

Bayer AG

Sun Pharmaceutical Industries Ltd

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Hansoh Pharmaceutical Group Company Ltd

Viatris Inc

Cian Healthcare Ltd. engages in the development and manufacture of pharmaceuticals, cosmeceuticals, and nutraceutical products. The company is headquartered in Pune, Maharashtra. The company went IPO on 2019-05-23. The firm is engaged in the manufacturing and marketing of pharmaceutical products. The company renders services for Third Party Pharmaceutical Manufacturing. The firm is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The firm also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. The company is also engaged in the business of manufacturing cosmetic products. The firm caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The firm's subsidiary includes Dr. Smith Biotech Private Limited.

Cian Healthcare Ltd

Cian Темп роста прибыли

Что такое Темп роста прибыли ?

Какой показатель «Темп роста прибыли» у Cian ?